ASPC Enduring Content

Reducing Residual CVD Risk: Adding Colchicine vs. Aggressive Lipid Lowering

Mike Wilkinson, MD
vs.
Daniel Soffer, MD

CAC/CCTA is the Imaging Modality of Choice in Refining ASCVD Risk in Primary Prevention

Seamus Whelton, MD, MPH
vs.
Matthew Budoff, MD, FASPC

Lp(a) in Primary Prevention is Actionable Today

Vera Bittner, MD, MSPH
vs.
Roger Blumenthal, MD, FASPC